For pharmaceutical companies Delta-8 serves as the platform for Kibron PLDscreen, a unique assay predicting phospholipidosis with unprecedented accuracy, as well as for physicochemical profiling of compounds, providing key parameters such as Kaw, TSA, CMC and surface pKa.
For chemical industries, including surfactant/detergent suppliers and users, Delta-8 represents a revolutionary platform for cost-efficient product optimization. High throughput screening of CMC and surface tension can be made more than 100 times faster compared to conventional methods, with minimal sample consumption.
As high content screening of molecules has become a standard procedure within the industry, it has started to undergo rapid evolution also into the academic sector. HTS allows discovery driven research projects to be tackled on a totally new scale, generating data at unprecedented rate.
The high throughput of Delta-8 opens new exciting possibilities for surface chemistry R&D, allowing comprehensive and truly efficient physicochemical profiling.
In ADME/tox Kibron Delta-8 has already provided novel data and correlations (Study on fraction absorbed). However, this is just the tip of the iceberg. Kibron wants to explore new application areas for Delta-8 and looks actively for collaboration in the this field.
Kibron Delta-8 represents a true breakthrough, making high throughput screening possible in surface chemistry, from CMC measurement to advanced drug discovery. 
